Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial

Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial

Introduction Childhood-onset obesity poses significant health risks, including early-onset type 2 diabetes, cardiovascular disease, and reduced quality of life. Hospital-based non-pharmacological obesity care can reduce childhood obesity, but 25% of children do not respond. Therefore, this study inv...

Full description

Saved in:
Bibliographic Details
Main Authors: Torben Hansen, Simon Birk Kjær Jensen, Lærke Bruun Madsen, Jens-Christian Holm, Sarah Byberg, Joachim Holt, Rasmus Michael Sandsdal, Louise Aas Holm, Bodil Just Christensen, Signe Torekov
Format: Article
Language:English
Published: BMJ Publishing Group 2024-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/11/e082446.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/14/11/e082446.full

Similar Items